Dentsply Sirona has completed its acquisition of Datum Dental, which it states has a strong OSSIX biomaterial portfolio.
Datum Dental is an Israeli-based company, which Dentsply Sirona states is known for its innovative dental regeneration products, such as the proprietary technology GLYMATRIX. According to Dentsply Sirona, Datum Dental complements its existing implant dentistry strategy around Ankylos, the Astra Tech Implant System, Xive and Atlantis. Dentsply Sirona also believes that Datum Dental has a strong R&D pipeline, with many promising products with differentiated value propositions. Gene Dorff, Group Vice President, Implants Product Group of Dentsply Sirona, said: “Datum Dental perfectly fits in our strategy to deliver innovative and meaningful solutions for our customers. The biomaterial sector is an important cornerstone of the future of dentistry. The acquisition is another important step for us to deliver on our purpose to empower dental professionals to provide patients with better dental care and make people smile